Tao Synergies Inc. Common Stock

TAOXNASDAQUSD
5.19 USD
0.29 (5.92%)AT CLOSE (11:59 AM EDT)
5.18
0.27 (5.18%)
POST MARKET (AS OF 06:36 PM EDT)
Post Market
AS OF 06:36 PM EDT
5.18
0.27 (5.18%)
🟢Market: OPEN
Open?$5.00
High?$5.49
Low?$5.00
Prev. Close?$4.90
Volume?111.7K
Avg. Volume?247.0K
VWAP?$5.23
Rel. Volume?0.45x
Bid / Ask
Bid?$4.41 × 100
Ask?$5.97 × 100
Spread?$1.56
Midpoint?$5.19
Valuation & Ratios
Market Cap?36.6M
Shares Out?7.5M
Float?7.2M
Float %?96.6%
P/E Ratio?N/A
P/B Ratio?1.74
EPS?-$3.91
Dividend?1.28%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?13.99Strong
Quick Ratio?13.99Strong
Cash Ratio?3.03Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
1.74CHEAP
P/S?
122.42HIGH
P/FCF?
N/A
EV/EBITDA?
-3.4CHEAP
EV/Sales?
104.04HIGH
Returns & Efficiency
ROE?
-138.7%WEAK
ROA?
-113.0%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$31.1M
News
Profile
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
Employees
4
Market Cap
36.6M
Industry
FINANCE SERVICES
Listed
2020-12-07
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK, NY 10036
Phone: (973) 242-0005